CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

about

CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Item

http://www.wikidata.org/entity/Q47894419

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CSF inflammatory markers and n ...... patients: the CINAMMON study.

@en

CSF inflammatory markers and n ...... patients: the CINAMMON study.

@nl

type

Item

label

CSF inflammatory markers and n ...... patients: the CINAMMON study.

@en

CSF inflammatory markers and n ...... patients: the CINAMMON study.

@nl

prefLabel

CSF inflammatory markers and n ...... patients: the CINAMMON study.

@en

CSF inflammatory markers and n ...... patients: the CINAMMON study.

@nl

P1476

CSF inflammatory markers and n ...... patients: the CINAMMON study.

@en

P2093

A Imaz

http://www.w3.org/2001/XMLSchema#string

A Pozniak

http://www.w3.org/2001/XMLSchema#string

B Gazzard

http://www.w3.org/2001/XMLSchema#string

D Podzamczer

http://www.w3.org/2001/XMLSchema#string

J Alonso

http://www.w3.org/2001/XMLSchema#string

J Niubó

http://www.w3.org/2001/XMLSchema#string

M Boffito

http://www.w3.org/2001/XMLSchema#string

N Davies

http://www.w3.org/2001/XMLSchema#string

R Fortuny

http://www.w3.org/2001/XMLSchema#string

S Mandalia

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive neuropsychology of HIV-associated neurocognitive disorders

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Inflammation, Immune Activation, and Antiretroviral Therapy in HIV

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-a

Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance?

The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals.

P2888

s13365-017-0600-6

P304

98-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13365-017-0600-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tristan J Barber

P577

2017-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29280108

http://www.w3.org/2001/XMLSchema#string